{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:20:10Z","timestamp":1768882810111,"version":"3.49.0"},"reference-count":53,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T00:00:00Z","timestamp":1142380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:p>On occasion, there arise questions or situations involving blood\u2010donor eligibility determination, which are not adequately addressed by the existing regulations and standards. In such instances, even the most experienced blood collector may be uncertain regarding the best course of action and unable to find adequate guidance in the standard blood banking references, regulations and literature. In order to examine this area in greater depth, the American Association of Blood Banks (AABB) sponsored a short topic session on \u2018Unique Donor Suitability Issues\u2019 at their 2004 annual meeting. The invited speakers were four seasoned physician medical directors, with a combined experience of over 40\u00a0years in blood collection at both regional and national levels. They were tasked with identifying and researching problematic areas in donor\u2010suitability determination, and suggesting an overall approach to dealing with such issues. They determined that three of the most problematic areas of eligibility evaluation included donors with: (1) disabilities, (2) disorders of haemostasis, and (3) trans\u2010sexual, homosexual and other unusual gender\u2010related issues. Each of these topics was presented in a 10\u2010min lecture, followed by an open format consisting of audience participation and panel discussion by the speakers. The session was additionally enhanced by a representative of the United States Food and Drug Administration (FDA) who participated as a member of the audience. This review presents the contents of the short topic session in an expanded form.<\/jats:p>","DOI":"10.1111\/j.1423-0410.2006.00758.x","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T14:15:30Z","timestamp":1142432130000},"page":"255-264","source":"Crossref","is-referenced-by-count":3,"title":["Unique donor\u2010suitability issues"],"prefix":"10.1111","volume":"90","author":[{"given":"R. A.","family":"Reik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"Burch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"R. R.","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Trainor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,3,15]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Americans with Disabilities Act of 1990 Pub. L. No. 101\u2010336 104 Stat. 327 as amended(July 26 1990).See 42 United States Code 12101 et seq. 2000"},{"key":"e_1_2_6_3_2","unstructured":"WaldropJ SternSM:Disability Status: 2000.United States Census Bureau March 2003. [Available fromhttp:\/\/www.census.gov\/prod\/2003pubs\/c2kbr\u201017.pdf]"},{"key":"e_1_2_6_4_2","unstructured":"Section 504 of the Rehabilitation Act of 1973 Pub. L. No. 93\u2010112 title V Section 504 87 Stat. 394 as amended (September 26 1973). See 29 United States Code Sect. 794 2005"},{"key":"e_1_2_6_5_2","unstructured":"Suitability of donor 21 Code of Federal Regulations Sect. 640.3 2005 and Collection of the blood 21 Code of Federal Regulations Sect. 640.4 2005"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00368.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2000.00240.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.381098440858.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7710024.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41111390.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(97)80011-9"},{"key":"e_1_2_6_12_2","first-page":"30S","article-title":"Compartment syndrome and hand amputation after whole blood phlebotomy: report of a case","volume":"39","author":"Gibble J","year":"1999","journal-title":"Transfusion"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36396182137.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40091036.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-194504000-00001"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-20567"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03278.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331978703801010"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03275.x"},{"key":"e_1_2_6_20_2","first-page":"47S","article-title":"Axilar thrombosis after platelet apheresis procedure","volume":"40","author":"Llop I","year":"2000","journal-title":"Transfusion"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-5-200109040-00013"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05715.x"},{"key":"e_1_2_6_23_2","unstructured":"BauerKA LipGYH: Evaluation of the patient with established venous thrombosis; in Rose BD (ed.): UptoDate. Waltham MA 2005"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-0037-1616136","article-title":"Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism \u2013 pooled analysis of 8 case\u2010control studies including 2310 cases and 3204 controls","volume":"86","author":"Emmerich J","year":"2001","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.7.1777"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.401S"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.7.2353"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000126126.79861.08"},{"key":"e_1_2_6_29_2","first-page":"265","article-title":"Hemorheological, coagulative and fibrinolytic changes during autologous blood donation","volume":"18","author":"Cliville X","year":"1998","journal-title":"Clin Hemorheol Microcirc"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1997.tb00036.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100120058775"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.5858\/2002-126-1382-TCS","article-title":"The contact system","volume":"126","author":"Kitchens CS","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04131.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.9.2549"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2001.0169"},{"key":"e_1_2_6_37_2","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington WJ","year":"1951","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830460206"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050391"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199710)56:2<119::AID-AJH8>3.0.CO;2-1"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb06899.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830250213"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1988.28188127960.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.9.2480.2480"},{"key":"e_1_2_6_45_2","unstructured":"BauerKA:Activated Protein C resistance and Factor V Leiden.UptoDate 2005;http:\/\/www.utdol.com last accessed October 1 2005"},{"key":"e_1_2_6_46_2","unstructured":"RosensonRS KangDS:Overview of Homocysteine.UptoDate 2005;http:\/\/www.utdol.com last accessed October 1 2005"},{"key":"e_1_2_6_47_2","unstructured":"BauerKA:Prothrombin Gene Mutation.UptoDate 2005;http:\/\/www.utdol.com last accessed October 1 2005"},{"key":"e_1_2_6_48_2","unstructured":"BauerKA:Protein C Deficiency.UptoDate 2005;http:\/\/www.utdol.com last accessed October 1 2005"},{"key":"e_1_2_6_49_2","unstructured":"BauerKA:Protein S Deficiency.UptoDate 2005;http:\/\/www.utdol.com last accessed October 1 2005"},{"key":"e_1_2_6_50_2","unstructured":"BauerKA:Antithrombin (ATIII) deficiency.UptoDate 2005;http:\/\/www.utdol.com last accessed October 1 2005"},{"key":"e_1_2_6_51_2","unstructured":"FDA:FDA Memorandum April 23 1992: Revised Recommendations for the Prevention of Human Immunodeficiency Virus (HIV) Transmission by Blood and Blood Products"},{"key":"e_1_2_6_52_2","unstructured":"CBER:Blood Frequently Asked Questions http:\/\/www.fda.gov\/cber\/faq\/bldfaq.htm"},{"key":"e_1_2_6_53_2","unstructured":"BPAC:BPAC Meeting Transcript September 14\u201315 2000 http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/cber00.htm#Blood"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00281.x"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2006.00758.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.2006.00758.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:16:16Z","timestamp":1696918576000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2006.00758.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,15]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1111\/j.1423-0410.2006.00758.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2006.00758.x","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,15]]}}}